Literature DB >> 17109643

Establishment and characterization of new mammary adenocarcinoma cell lines derived from double transgenic mice expressing GFP and neu oncogene.

M G Sacco1, F Faggioli, S Soldati, L Gribaldo, A Collotta, F Pariselli, I Malerba, A Musio, C Montagna, E Mira Catò, P Vezzoni.   

Abstract

A new murine cell line, named GFPneu, was established from a mammary adenocarcinoma arising in double transgenic MMTVneu x CMV-GFP mice. Breast tumours develop in 100% of females after 2 months latency, as a result of the over-expression of the activated rat neu oncogene in the mammary glands. All tissues, and in particular the breast tumours, express the GFP protein. This cell line was tumorigenic when inoculated into nude mice and the derived tumours showed the same histological features as the primaries from which they were isolated. Their histopathology reproduces many characteristics of human breast adenocarcinomas, in particular their ability to metastasize. The GFP marker allows us to visualize the presence of lung metastases in fresh tissues immediately, to confirm the histopathology. From a lung metastatic fluorescent nodule, we derived a further cell line, named MTP-GFP, which we also characterized. These two cell lines could be useful to study the role played by the neu oncogene in the maintenance of the transformed phenotype, in the metastatic process, to test novel therapeutic strategies to inhibit primary tumour growth and to observe the generation of distant metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109643      PMCID: PMC6760741          DOI: 10.1111/j.1365-2184.2006.00401.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  24 in total

1.  Direct cloning of human ovarian carcinoma cells in agar.

Authors:  A W Hamburger; S E Salmon; M B Kim; J M Trent; B J Soehnlen; D S Alberts; H J Schmidt
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

Review 2.  Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.

Authors:  P K Pattengale; T A Stewart; A Leder; E Sinn; W Muller; I Tepler; E Schmidt; P Leder
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice.

Authors:  M Sacco; S Benedetti; E M Catò; M Caniatti; R Ceruti; E Scanziani; B Pirola; A Villa; G Finocchiaro; P Vezzoni
Journal:  Gene Ther       Date:  1999-11       Impact factor: 5.250

4.  Combined effects on tumor growth and metastasis by anti-estrogenic and antiangiogenic therapies in MMTV-neu mice.

Authors:  M G Sacco; S Soldati; E Mira Cató; L Cattaneo; G Pratesi; E Scanziani; P Vezzoni
Journal:  Gene Ther       Date:  2002-10       Impact factor: 5.250

Review 5.  Overview of the biologic markers of breast cancer.

Authors:  K Porter-Jordan; M E Lippman
Journal:  Hematol Oncol Clin North Am       Date:  1994-02       Impact factor: 3.722

6.  Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice.

Authors:  F Lucchini; M G Sacco; N Hu; A Villa; J Brown; L Cesano; L Mangiarini; G Rindi; S Kindl; F Sessa
Journal:  Cancer Lett       Date:  1992-07-10       Impact factor: 8.679

Review 7.  Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.

Authors:  H C Maguire; M I Greene
Journal:  Pathobiology       Date:  1990       Impact factor: 4.342

Review 8.  The biology of erbB-2/neu/HER-2 and its role in cancer.

Authors:  N E Hynes; D F Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

9.  Local regression of breast tumors following intramammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase.

Authors:  M G Sacco; L Mangiarini; A Villa; P Macchi; O Barbieri; M C Sacchi; E Monteggia; V Fasolo; P Vezzoni; L Clerici
Journal:  Gene Ther       Date:  1995-09       Impact factor: 5.250

Review 10.  Clinical breast cancer, new developments in selection and endocrine treatment of patients.

Authors:  J G Klijn; P M Berns; M Bontenbal; J Alexieva-Figusch; J A Foekens
Journal:  J Steroid Biochem Mol Biol       Date:  1992-09       Impact factor: 4.292

View more
  1 in total

1.  Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer.

Authors:  Cesar F Ortega-Cava; Srikumar M Raja; Zenab Laiq; Tameka A Bailey; Haitao Luan; Bhopal Mohapatra; Stetson H Williams; Aaron C Ericsson; Rasna Goswami; Manjari Dimri; Lei Duan; Vimla Band; Mayumi Naramura; Hamid Band
Journal:  J Carcinog       Date:  2011-11-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.